Enorama Pharma AB (ERMA) — Cash Flow Reinvestment Rate
Enorama Pharma AB (ERMA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2015, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr760.00K. See ERMA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Enorama Pharma AB Cash Flow Reinvestment Rate (2014–2015)
Historical reinvestment intensity for Enorama Pharma AB across 2 annual periods. For the full cash flow conversion analysis, see Enorama Pharma AB operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Enorama Pharma AB (2014–2015)
Year-by-year capital reinvestment analysis for Enorama Pharma AB. See financial agility of Enorama Pharma AB to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 4.15x | Skr1.99 Million | Skr480.00K | Skr1.99 Million | ▼ -7.8% |
| 2014 | 4.50x | Skr1.38 Million | Skr307.00K | Skr1.38 Million | — |